Ranbaxy Laboratories reports consolidated net profit of Rs 477.76 crore in Q2FY15

28 Oct 2014 Evaluate

Ranbaxy Laboratories has reported results for second quarter ended September 30, 2014.

The company has reported a net loss of Rs 368.26 crore for the quarter under review as compared to a net loss of Rs 842.23 crore for the same quarter in the previous year. Total income of the company has decreased 8.92% at Rs 1338.93 crore for Q2FY15 as compared Rs 1470.19 crore for the corresponding quarter previous year.

On consolidated basis, the company has posted a net profit after taxes and minority interest of Rs 477.76 crore for the quarter as against a net loss of Rs 454.17 crore in the September quarter of previous fiscal. The company’s total income has increased by 15.92% at Rs 3277.88 crore for the quarter from Rs 2827.73 crore in the similar quarter of previous year.

Peers
Company Name CMP
Sun Pharma Inds. 1518.35
Dr. Reddys Lab 6218.90
Cipla 1412.00
Zydus Lifesciences 956.30
Lupin 1659.50
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.